echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tianyao's methylprednisolone sodium succinate for injection passed the consistency evaluation

    Tianyao's methylprednisolone sodium succinate for injection passed the consistency evaluation

    • Last Update: 2021-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 30, Tianyao issued an announcement stating that its subsidiary Tianjin Jinyao Pharmaceutical Co.


    Methylprednisolone sodium succinate for injection is a glucocorticoid drugs, mainly for anti-inflammatory therapy, immunosuppressive therapy, the treatment of blood diseases and tumors, the treatment of shock and the like


    Up to now, Jinyao Pharmaceutical has invested about 10 million yuan in research and development projects for the consistency evaluation of methylprednisolone sodium succinate for injection (40mg specifications), and has invested about R&D projects for all specifications of methylprednisolone sodium succinate for injection.


    The original manufacturer of methylprednisolone sodium succinate for injection is Pfizer, the trade name is SOLU-MEDROL.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.